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 In this issue of  Kidney International , Cui 
and associates 1 show evidence that all 
healthy individuals have low levels of cir-
culating natural autoantibodies (NAAs) 
specifi c for myeloperoxidase, proteinase 
3, and glomerular basement membrane 
(GBM) type IV collagen. Although requir-
ing special unmasking methods for detec-
tion, these NAAs have the same specifi city 
as anti-neutrophil cytoplasmic antibodies 
(ANCAs) and anti-GBM antibodies that 
are pathogenic in patients with ANCA 
disease and anti-GBM disease. But weren ’ t 
we taught in medical school that normal 
healthy individuals do not produce 
autoantibodies? Haven ’ t we heard the 
memorable terms  ‘ forbidden clones ’ and 
 ‘ horror autotoxicus ’ ? How has  Kidney 
International allowed such heresy to be 
published? Actually, if you have not heard 
about natural autoantibodies, it is time 
you did. In fact, the occurrence of natural 
autoantibodies has been reported in the 
medical literature beginning at the time 
Ehrlich fi rst espoused his theory of  horror 
autotoxicus . 2 At least in part because they 
are technically diffi  cult to document, but 
probably more because an entrenched 
dogma is difficult to overcome, the 
frequency and importance of NAAs are 
not widely recognized. 
 Paul Ehrlich, a pioneer in the elucida-
tion of humoral immunity, envisioned 
that individuals produce antibodies spe-
cifi c for every possible foreign (non-self) 
antigen before being exposed to the anti-
gens. 2 However, he posited in his  horror 
autotoxicus theory that antibodies against 
self antigens that injured one ’ s own cells 
(autotoxins) would be  ‘ dysteleologic ’ and 
thus would not be produced. 
 At the same time that Ehrlich was dis-
counting the possibility of autoimmunity, 
Elie Metchnikoff  3 and Alexander Besredka 4 
viewed the immune system as being involved 
both in the homeostasis of self constitu-
ents and in immune responses to non-self. 
Th us, unlike Ehrlich, Metchnikoff  and 
Besredka accepted immune responsivity 
to self (that is, autoimmunity) as a natural 
process. Besredka postulated that anti-
bodies reactive with self might be held in 
check by anti-antibodies. 
 Sir Frank Macfarlane Burnet shared 
Ehrlich ’ s aversion to autoimmunity and 
included in his landmark clonal selection 
theory of acquired immunity a clonal 
deletion caveat to guard against  horror 
autotoxicus . 5 According to the clonal 
selection theory (using current termi-
nology), each B lymphocyte has on its 
surface antibodies with specifi city for a 
particular antigen, and binding to this 
antigen results in clonal proliferation of 
this B cell and production of increased 
quantities of antibodies with specifi city 
for the antigen that selectively stimulated 
this clone. Clonal deletion of  ‘ forbidden 
clones ’ during fetal life is a component of 
this theory that addresses self-tolerance 
and autoimmunity. Th e clonal deletion 
theory posits that B-cell interaction with 
self antigens results in functional if not 
actual deletion of the B cell from the 
immune repertoire. Since the publication 
of Burnet ’ s theory, overwhelming evi-
dence has accrued supporting lymphocyte 
clonal selection as the basis for acquired 
immunity. Conversely, overwhelming evi-
dence has accrued disproving the univer-
sality of deletion of self-reactive  ‘ forbidden ’ 
lymphocyte clones. In addition to the ear-
lier studies of Metchnikoff  and Besredka 
that demonstrated the presence of autoan-
tibodies, in 1904, Julius Donath and Karl 
Landsteiner reported the fi rst solid evi-
dence that autoantibodies can cause disease 
by showing that autoantibodies ( ‘ hemo-
lysins ’ ) caused paroxysmal cold hemoglob-
inuria. 6 In spite of innumerable reports in 
the medical literature describing a wide 
variety of autoimmune disease, over the 
ensuing decades the concept of autoimmu-
nity was begrudgingly accepted only aft er 
the evidence became incontrovertible. 
 Th e forbidden clone theory can be recon-
ciled with autoimmune disease by the con-
tention that this disease state is a grossly 
aberrant condition that deviates dramati-
cally from natural immune mechanisms. 
On the other hand, natural autoimmunity, 
including NAAs, present in everyone is 
more diffi  cult to reconcile with the views 
of Ehrlich and Burnet that the immune 
system is a protective mechanism designed 
expressly to recognize between self and 
non-self. The dominant dogma that 
autoimmune disease arises as an aberrant 
state rather than as a dysregulation of a 
natural process has greatly infl uenced the 
direction of research on the pathogenesis 
of autoimmune disease. Martin Weigert 
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has contended that  ‘ the concepts that lead 
to rhetoric such as  ‘ repertoire purging ’ and 
 ‘ forbidden clones ’ have had a paralytic 
eff ect on research in autoimmunity and 
have delayed the recognition that the 
immune-cell repertoire contains many self-
reactive cells and potential precursors to 
autoantibody producers. ’ 7 
 Th is resistance to accepting the presence 
and importance of NAAs has contributed 
to the reticence to accept Jerne ’ s idiotypic 
network theory of immune regulation. 
Jerne extended Besredka ’ s concept of 
immune regulation by anti-antibodies into 
the idiotypic network theory, in which the 
immune system maintains homeostasis by 
reciprocal interactions between antibodies 
that recognize the antigen-binding sites of 
other antibodies (that is, anti-antibodies). 8 
One antigen-binding site is designated the 
idiotope and the other the anti-idiotope, 
although which is which is essentially arbi-
trary, and the antibodies displaying these 
binding sites are designated idiotypic and 
anti-idiotypic antibodies. According to the 
Jerne network theory, the immune system 
is regulated by an intricate balance between 
idiotypic / anti-idiotypic interactions 
among B cells and their antibodies. Anti-
antibodies (for example, anti-idiotypic 
antibodies) are NAAs, and thus acceptance 
of Jerne ’ s theory requires  ‘ belief  ’ in NAAs. 
In a remarkably blunt diatribe titled  ‘ Th e 
concept of functional idiotype network for 
immune regulation mocks all and com-
forts none, ’ Melvin Cohn totally discounted 
the Jerne idiotypic network theory, prima-
rily because it does not distinguish between 
self and non-self. 9 Th is refl ects the persist-
ence of the  horror autotoxicus dogma well 
into the modern era of immunology. 
 In addition to the seminal observations 
by Cui  et al. 1 in this issue of  Kidney Inter-
national , many lines of convincing evi-
dence have been published that solidly 
establish the presence and physiological 
importance of NAAs (reviewed by 
Avrameas  et al. 10 ). NAAs have been 
shown to have important roles in many 
biological processes, including but not 
limited to (1) participation in fi rst-line 
defense against toxins and infectious 
pathogens, (2) immune homeostasis 
through anti-idiotypic regulation of B 
cells and T cells, (3) antigen presentation 
to T cells, B cells, and antigen-presenting 
cells, (4) removal of apoptotic cells and 
other eff ete cells and molecules, and (5) 
cell regulation by ligation of signaling 
pathway receptors. Innate natural 
immune reactivity with self molecules is 
useful for initial defense against patho-
gens, because many pathogens express 
antigens that mimic self molecules that 
are ligands for receptors that pathogens 
use for entering tissues and cells, and 
neutralizing antimicrobial defenses. Con-
ceptually, baseline endogenous and exog-
enous autoantigen levels maintain NAA 
homeostasis that can be disrupted by 
greater levels of antigen stimulation. Th is 
could initiate physiological housekeeping 
or defense functions or, in extreme cir-
cumstances paired with ineff ective regu-
latory control, could result in pathological 
autoimmune processes. By this scenario, 
autoimmune disease would arise through 
dysregulation of the lymphocytes that 
produce NAAs, rather than through the 
persistence of a forbidden fetal clone or 
the aberrant emergence of an autoim-
mune clone by somatic mutation. 
 Th e homeostatic balance between self- 
and non-self-reactivity could be upset by 
dysregulation in immune reactivity or by 
abnormal antigenic stimulation. Although 
highly specifi c NAAs occur, NAAs have a 
predilection to be polyreactive with low to 
moderate affi  nity, oft en are of IgM isotype, 
and typically have minimal or no somatic 
mutation of antigen-binding variable 
regions (reviewed by Elkon and Casali 11 ). 
By contrast, pathogenic autoantibodies are 
of higher titer, oft en have class switching 
to IgG, and have higher affi  nity and greater 
somatic hypermutation of antigen-binding 
regions. Conceptually, an appropriate level 
of immune reactivity with self is required 
for normal immune homeostasis, whereas 
an inappropriately regulated increased and 
altered reactivity with self results in 
autoimmune disease ( Figure 1 ). Alter-
natively, too much or too little reactivity 
with non-self results in hypersensitivity or 
immunodefi ciency disease, respectively. 
 Th e article by Cui  et al. 1 should not only 
stimulate new ideas about the pathogenesis 
of ANCA disease, anti-GBM disease, and 
other autoimmune disease but also should 
influence our concepts of the effects of 
immunosuppressive therapy for autoim-
mune disease. If NAAs are present during 
health and have an immune-regulatory 
role, NAAs probably also are present during 
autoimmune disease and may continue to 
participate in immune regulation. If so, 
the role of anti-B cell therapy (for exam-
ple, with anti-CD20 antibodies) and 
intravenous IgG therapy, which has major 
effects on idiotypic network immune 
regulation, must be considered in light of 
not only specifi c direct eff ects on the path-
ogenic autoantibodies but also the regula-
tory network of interacting pathogenic 
and natural auto antibodies, including 
networked anti- idiotypic antibodies. 
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 Figure 1  |  Normal immune homeostasis involves a balance between T cells, B cells, and antibodies 
that are reactive with self, non-self, or both. Disease results when there is an imbalance of immune 
responsivity with either too little immune defense against foreign pathogens (immune deficiency 
disease), more immune response to non-self antigens than is beneficial (allergic or hypersensitivity 
disease), or more immune response to self antigens than is beneficial (autoimmune disease). 
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 So, rather than normally being purged 
of anti-self antibodies and lymphocytes by 
 horror autotoxicus and elimination of for-
bidden clones, all of us are bathed in ben-
eficial autoantibodies that react with 
ourselves. If so, pathogenic autoimmunity 
can be envisioned more as a dysregulation 
of natural homeo static autoimmunity 
rather than the onset of a previously absent 
state of self-recognition. 
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 Lead-time bias in studies of 
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 Observational studies have suggested a link between higher serum 
phosphate, calcium, parathyroid hormone levels, and cardiovascular 
mortality. The administration of cinacalcet has proven efficient in the 
treatment of secondary hyperparathyroidism among hemodialysis 
patients. In an observational study by Block  et al. , cinacalcet treatment 
is associated with a much improved all-cause and cardiovascular 
mortality. However, the results should be interpreted cautiously, as 
observational studies may be influenced by bias. This Commentary 
discusses the role of some common potential biases. 
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 Nephrologists try hard to unveil the etio-
logy behind the increased cardiovascular 
mortality among hemodialysis patients. 
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Observational studies have been able to 
show that a high plasma phosphorus and 
calcium are independent risk factors for 
cardiovascular events, and all-cause mor-
tality. 1 Th e relationship of parathyroid hor-
mone (PTH) is more complex; both high 
and low values are associated with 
increased mortality. Control of calcium, 
phosphate, and PTH has proven essential; 
the length of time for which a dialysis 
patient achieves the targets, and simultane-
ous control of all three of them, are associ-
ated with improved survival. 2 Because 
these three laboratory values are closely 
interconnected, we look with enthusiasm 
at cinacalcet, which has the potential to 
improve all of them. In addition to excel-
lent results on laboratory parameters, cina-
calcet has also shown favorable eff ects on 
cardiovascular hospitalization, fractures, 
parathyroidectomy, and quality of life. 3 
However, data on hard clinical outcomes, 
such as mortality, have been scarce. Dur-
ing the past decade, a number of negative 
randomized controlled trials have 
emerged among hemodialysis patients. 
These trials have showed that neither 
increasing the dose of hemodialysis or 
peritoneal dialysis, nor treating patients 
with statins, B vitamins, or erythropoietin, 
had any eff ect on the survival in this high-
risk population. 4 In the light of all the nega-
tive trials, the study by Block  et al. 5 (this 
issue) brings new hope to the renal com-
munity, as it shows a 27 % improvement in 
all-cause mortality among cinacalcet-treated 
compared with non-treated patients. 
 Th ere is reason, however, to regard the 
fi ndings of this observational study with 
some caution. Indeed, some of the above-
mentioned negative randomized trials were 
preceded by observational studies that 
showed favorable eff ects of intervention. A 
frequent problem in observational studies 
is bias due to  ‘ confounding by indication. ’ 6 
Th is means that the very reason for an indi-
vidual to receive a treatment or not receive 
a treatment is associated with factors (oft en 
disease status) that in turn are related to the 
outcome — in this example, mortality. Epi-
demiologists try to deal with confounding 
by indication by adjustments for as many 
risk factors as possible that are related to 
the diff erences in treatment assignment. 
Th e problem is that we can only adjust for 
measured covariates. Sometimes diff er-
ences between patients are subtle, and more 
diffi  cult to describe than a simple statement 
of comorbid conditions can do. How can 
we describe the  ‘ clinician ’ s eye ’ for the 
patient ’ s general condition? Th us, unmeas-
ured covariates and insuffi  cient resolution 
among the measured ones may give rise to 
residual confounding by indication. In the 
paper by Block  et al. , 5 the results were 
adjusted for the fact that the patients receiv-
ing cinacalcet were younger and had 
lower prevalence of diabetes, fewer hospital 
days, and higher body mass index 
and serum albumin levels. In addition, the 
